Out-Licensing of Innovative Finished Dosage Forms

Midas Pharma offers a broad range of innovative finished dosage forms for various indications, including a reliable supply chain. Our fixed-dose combinations and optimized dosage forms enable our licensees and distribution partners to mark themselves off from the competition.

Indication Fields

Our products cover a broad range of indication fields. These include:

  • Cardiovascular system
  • Antineoplastic and immunomodulatory agents
  • Urology
  • Central nervous system
  • Allergy and colds
  • Anti-infectives for systemic use

We steadily expand our portfolio of products developed exclusively by or in cooperation with Midas. Midas has established itself as an expert in fixed-dose combinations which significantly improve patient compliance by substituting several individual drugs. In this process, we work together with renowned cooperation partners, all of whom are at least EU-GMP certified.

Further, we offer numerous additional products for which Midas is holding the exclusive mandate from its partners for out-licensing.

  • Generics

    Thanks to our global presence and networks established over decades, Midas represents a number of internationally renowned companies that develop and subsequently manufacture generic drugs for European and also international markets.

    Our goal is to enable our customers to achieve the earliest possible market launch. We cover a wide range of indications and technologies - from simply tablets to oral and injectable solutions to special dosage forms.

    Midas has the expertise and infrastructure to cover all stages of the pharmaceutical value chain. This makes it possible for us to offer all-in-one solutions that meet the specific needs of each customer.

  • Contract Development

    The product you are looking for is not available for licensing? Midas will take over the development on your behalf, with a comprehensive management of all project phases if desired.

    As an experienced and reliable partner, Midas has been successfully supporting its customers in their development projects for many years - from the initial idea to the submission of the final documentation.

    Learn more about the contract development of pharmaceuticals, biopharmaceuticals and biosimilars.

    Learn more

For more information about our products, please contact us!

Your Contact

Heike Sagi

Heike Sagi

Business Development & Licensing
Senior Director

Midas Pharma GmbH
Rheinstraße 49
55218 Ingelheim
Germany

FDF Technology Transfer

Midas will proactively steer your projects from kick-off to commercial production. 

Share this page